NCT01249651View on ClinicalTrials.gov

To Assess the Efficacy of Esomeprazole 40 mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole

PHASE4CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Heartburn
Interventions
DRUG

esomeprazole 40 mg

esomeprazole 40 mg once daily, 8 weeks

Trial Locations (1)

Unknown

Research Site, Beijing

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
collaborator

Quintiles, Inc.

INDUSTRY

lead

AstraZeneca

INDUSTRY